David E Brown

Array ( [id] => 3995361 [patent_doc_number] => RE036420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Percutaneous preparation of tulobuterol' [patent_app_type] => 2 [patent_app_number] => 9/129996 [patent_app_country] => US [patent_app_date] => 1998-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3092 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/036/RE036420.pdf [firstpage_image] =>[orig_patent_app_number] => 129996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4003022 [patent_doc_number] => 05962013 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Monolithic matrix transdermal delivery system for administering molsidomine' [patent_app_type] => 1 [patent_app_number] => 9/128909 [patent_app_country] => US [patent_app_date] => 1998-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6983 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962013.pdf [firstpage_image] =>[orig_patent_app_number] => 128909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935912 [patent_doc_number] => 05989590 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Oral delivery of discrete units' [patent_app_type] => 1 [patent_app_number] => 9/100202 [patent_app_country] => US [patent_app_date] => 1998-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 15 [patent_no_of_words] => 4726 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989590.pdf [firstpage_image] =>[orig_patent_app_number] => 100202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3975182 [patent_doc_number] => 05904934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-18 [patent_title] => 'Ruminal drug delivery device' [patent_app_type] => 1 [patent_app_number] => 9/082196 [patent_app_country] => US [patent_app_date] => 1998-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 5626 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/904/05904934.pdf [firstpage_image] =>[orig_patent_app_number] => 082196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3958321 [patent_doc_number] => 05900250 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-04 [patent_title] => 'Monoglyceride/lactate ester permeation enhancer for oxybutnin' [patent_app_type] => 1 [patent_app_number] => 9/070492 [patent_app_country] => US [patent_app_date] => 1998-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 7898 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/900/05900250.pdf [firstpage_image] =>[orig_patent_app_number] => 070492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3929125 [patent_doc_number] => 05972376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Transdermal system of tacrine/selegilin-plaster' [patent_app_type] => 1 [patent_app_number] => 9/043231 [patent_app_country] => US [patent_app_date] => 1998-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2961 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972376.pdf [firstpage_image] =>[orig_patent_app_number] => 043231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4042616 [patent_doc_number] => 05968533 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Skin care compositions and methods' [patent_app_type] => 1 [patent_app_number] => 9/020762 [patent_app_country] => US [patent_app_date] => 1998-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 6542 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968533.pdf [firstpage_image] =>[orig_patent_app_number] => 020762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3987477 [patent_doc_number] => 05985311 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Transdermal hormone patch' [patent_app_type] => 1 [patent_app_number] => 9/010534 [patent_app_country] => US [patent_app_date] => 1998-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2729 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985311.pdf [firstpage_image] =>[orig_patent_app_number] => 010534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047035 [patent_doc_number] => 05932240 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Multidose transdermal drug delivery system' [patent_app_type] => 1 [patent_app_number] => 8/986370 [patent_app_country] => US [patent_app_date] => 1997-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5162 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932240.pdf [firstpage_image] =>[orig_patent_app_number] => 986370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920964 [patent_doc_number] => 05952000 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Fatty acid esters of lactic acid salts as permeation enhancers' [patent_app_type] => 1 [patent_app_number] => 8/959946 [patent_app_country] => US [patent_app_date] => 1997-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9283 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952000.pdf [firstpage_image] =>[orig_patent_app_number] => 959946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4218653 [patent_doc_number] => 06010715 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Transdermal patch incorporating a polymer film incorporated with an active agent' [patent_app_type] => 1 [patent_app_number] => 8/954861 [patent_app_country] => US [patent_app_date] => 1997-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 17064 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010715.pdf [firstpage_image] =>[orig_patent_app_number] => 954861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991999 [patent_doc_number] => 05922353 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Interlocking couplings for osmotic delivery devices' [patent_app_type] => 1 [patent_app_number] => 8/947110 [patent_app_country] => US [patent_app_date] => 1997-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 4008 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922353.pdf [firstpage_image] =>[orig_patent_app_number] => 947110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768684 [patent_doc_number] => 05807571 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Transdermal therapeutic systems for administering indole serotonin agonists' [patent_app_type] => 1 [patent_app_number] => 8/946658 [patent_app_country] => US [patent_app_date] => 1997-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2517 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807571.pdf [firstpage_image] =>[orig_patent_app_number] => 946658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3970958 [patent_doc_number] => 05916587 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Transdermal delivery matrix for piroxicam' [patent_app_type] => 1 [patent_app_number] => 8/943140 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 3698 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916587.pdf [firstpage_image] =>[orig_patent_app_number] => 943140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3987361 [patent_doc_number] => 05985305 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Sustained delivery of an active agent using an implantable system' [patent_app_type] => 1 [patent_app_number] => 8/943007 [patent_app_country] => US [patent_app_date] => 1997-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 8040 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985305.pdf [firstpage_image] =>[orig_patent_app_number] => 943007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4042802 [patent_doc_number] => 05968547 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Method of providing sustained analgesia with buprenorphine' [patent_app_type] => 1 [patent_app_number] => 8/939068 [patent_app_country] => US [patent_app_date] => 1997-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 14 [patent_no_of_words] => 20511 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968547.pdf [firstpage_image] =>[orig_patent_app_number] => 939068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3975120 [patent_doc_number] => 05904930 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-18 [patent_title] => 'Transdermal system in the form of a patch comprising a tamoxifen derivative' [patent_app_type] => 1 [patent_app_number] => 8/924742 [patent_app_country] => US [patent_app_date] => 1997-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2149 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/904/05904930.pdf [firstpage_image] =>[orig_patent_app_number] => 924742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3993839 [patent_doc_number] => 05858393 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Transdermal formulation' [patent_app_type] => 1 [patent_app_number] => 8/918141 [patent_app_country] => US [patent_app_date] => 1997-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4119 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858393.pdf [firstpage_image] =>[orig_patent_app_number] => 918141 [rel_patent_id] =>[rel_patent_doc_number] =>)